The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Cable, Jemma C ^a   Tan, Garry D ^a   Alexander, Stephen PH ^a   O'Sullivan, Saoirse E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adipocytes; BMI; Endocannabinoid system; Fatty acid amide hydrolase; Glucose; Human; Insulin; Monoacylglycerol lipase

Indexed keywords

ACYLGLYCEROL LIPASE; ADIPONECTIN; ENDOCANNABINOID; FATTY ACID AMIDASE; GLUCOSE; INSULIN; LEPTIN; RESISTIN; ADIPOCYTOKINE; AMIDASE; FATTY-ACID AMIDE HYDROLASE;

ADIPOCYTE; ADULT; ARM CIRCUMFERENCE; ARTICLE; BODY MASS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; ISOTOPE LABELING; MALE; NORMAL HUMAN; OBESITY; PROTEIN BLOOD LEVEL; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE; WAIST CIRCUMFERENCE; BLOOD; CHEMISTRY; CYTOLOGY; ENZYME ASSAY; ENZYMOLOGY; METABOLISM; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOKINES; ADULT; AMIDOHYDROLASES; BLOOD GLUCOSE; BODY MASS INDEX; ENDOCANNABINOIDS; ENZYME ASSAYS; FEMALE; HUMANS; INSULIN; MALE; MONOACYLGLYCEROL LIPASES; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79961107777     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-129     Document Type: Article

References (37)

1. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. Devane W, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R, Science 1992 258 1946 1949 10.1126/science.1470919 1470919 (Pubitemid 23026736)
2. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al. Biochem Pharmacol 1995 50 1 83 90 7605349
3. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K, Biochem Biophys Res Commun 1995 215 1 89 97 10.1006/bbrc.1995.2437 7575630
4. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Dinh TP, Freund TF, Piomelli D, Chem Phys Lipids 2002 121 1-2 149 158 10.1016/S0009-3084(02)00150-0 12505697 (Pubitemid 36044549)
5. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Cravatt B, Giang D, Mayfield S, Boger D, Lerner R, Gilula N, Nature 1996 384 83 87 10.1038/384083a0 8900284 (Pubitemid 26374593)
6. Dysregulation of the Endocannabinoid System in Obesity. Engeli S, J Neuroendocrinol 2008 20 Suppl 1 110 115 18426509 (Pubitemid 351559284)
7. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, et al. J Clin Endocrinol Metab 2006 91 8 3171 3180 10.1210/jc.2005-2679 16684820 (Pubitemid 44271774)
8. Identification of Endocannabinoids and Related Compounds in Human Fat Cells. Gonthier M, Hoareau L, Festy F, Matias I, Valenti M, Bès-Houtmann S, Rouch C, Robert-Da Silva C, Chesne S, Lefebvre d'Hellencourt C, et al. Obesity 2007 15 4 837 845 10.1038/oby.2007.581 17426318 (Pubitemid 46740958)
9. The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids. D'eon T, Pierce K, Roix J, Tyler A, Chen H, Teixeira S, Diabetes 2008 57 1262 1268 10.2337/db07-1186 18276766
10. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, Casellas P, Eur J Pharmacol 2005 517 3 174 181 10.1016/j.ejphar.2005.05. 032 15987634 (Pubitemid 40977892)
11. Activation of the Peripheral Endocannabinoid System in Human Obesity. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkal S, Pacher P, Harvey-White J, Luft F, Sharma A, et al. Diabetes 2005 54 2838 2834 10.2337/diabetes.54.10.2838 16186383 (Pubitemid 41401077)
12. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Roche R, Hoareau L, Bes-Houtmann S, Gonthier MP, Laborde C, Baron JF, Haffaf Y, Cesari M, Festy F, Histochem Cell Biol 2006 126 2 177 187 10.1007/s00418-005-0127-4 16395612
13. The role of the endocannabinoid system in lipogenesis and fatty acid metabolism. Vettor R, Pagano C, Best Pract Res Clin Endocrinol Metab 2009 23 1 51 63 10.1016/j.beem.2008.10.002 19285260
14. Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity. Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, Bátkai S, Pacher P, Schön M, Jordan J, Stumvoli M, Diabetes 2006 55 3053 3060 10.2337/db06-0812 17065342 (Pubitemid 44923642)
15. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Cote M, Matias I, Lemieux I, Petrosino S, Almeras N, Despres JP, Di Marzo V, Int J Obes (Lond) 2007 31 4 692 699 (Pubitemid 46482358)
16. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Di Marzo V, Cote M, Matias I, Lemieux I, Arsenault BJ, Cartier A, Piscitelli F, Petrosino S, Almeras N, Despres JP, Diabetologia 2009 52 2 213 217 10.1007/s00125-008-1178-6 18972095
17. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G, et al. J Clin Endocrinol Metab 2007 92 12 4810 4819 10.1210/jc.2007-0768 17785353 (Pubitemid 350223464)
18. Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals. Murdolo G, Kempf K, Hammarstedt A, Herder C, Smith U, Jansson PA, J Endocrinol Invest 2007 30 8 C17 21 17923791
19. Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level. Lofgren P, Sjolin E, Wahlen K, Hoffstedt J, J Clin Endocrinol Metab 2007 92 4 1555 1559 10.1210/jc.2006-2240 17284627 (Pubitemid 46556439)
20. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Sipe JC, Waalen J, Gerber A, Beutler E, Int J Obes (Lond) 2005 29 7 755 759 10.1038/sj.ijo.0802954 (Pubitemid 40897010)
21. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. Spoto B, Fezza F, Parlongo G, Battista N, Sgro' E, Gasperi V, Zoccali C, Maccarrone M, Biochimie 2006 88 1889 1897 10.1016/j.biochi.2006.07.019 16949718 (Pubitemid 44881190)
22. Measurement Techniques in Anthropometry. Norton K, Olds T, Anthropometrica, Norton K, Olds T, 1996 47 53
23. Metabolism of Isolated Fat Cells. Rodbell M, J Biol Chem 1964 239 2 375 380 14169133
24. A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. Boldrup L, Wilson S, Barbier A, Fowler C, J Biochem Biophys Meth 2004 60 171 177 10.1016/j.jbbm.2004.04.020 15262451 (Pubitemid 38953060)
25. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese. Bennetzen MF, Nielsen TS, Paulsen SK, Bendix J, Fisker S, Jessen N, Lund S, Richelsen B, Pedersen SB, Eur J Clin Invest 2010 40 2 121 126 10.1111/j.1365-2362.2009.02231.x 20039929
26. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, Ueda N, Biochim Biophys Acta 2005 1736 3 211 220 16154384 (Pubitemid 41423705)
27. Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets. de Luis DA, Sagrado MG, Aller R, Izaola O, Conde R, Metabolism 2010 59 9 1387 1392 10.1016/j.metabol.2009.12.029 20102775
28. The endocannabinoid system: Its roles in energy balance and potential as a target for obesity treatment. Aurore A, Gonthier M-P, Int J Biochem Cell Biol 2010 42 11 1788 1801 10.1016/j.biocel.2010.06.002 20541029
29. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Bermudez-Silva F, Viveros M, McPartland J, Rodriguez de Fonseca F, Pharm Biochem Behav 2010 95 4 375 382 10.1016/j.pbb.2010.03.012
30. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Annuzzi G, Piscitelli F, Di Marino L, Patti L, Giacco R, Costabile G, Bozzetto L, Riccardi G, Verde R, Petrosino S, et al. Lipids Health Dis 2010 9 43 10.1186/1476-511X-9-43 20426869
31. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després J, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand O, Poirier P, Arter Thromb Vasc Biol 2008 28 1039 1049 10.1161/ATVBAHA.107.159228
32. C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2. de Luis D, Sagrado M, Aller R, Izaola O, Conde R, Romero E, Diab Res Clin Pract 2010 88 1 76 80 10.1016/j.diabres.2009.12.019
33. Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. Maccarrone M, Di Rienzo M, Finazzi-Agr A, Rossi A, J Biol Chem 2003 278 15 13318 13324 10.1074/jbc.M211248200 12556536 (Pubitemid 36800103)
34. Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone. Maccarrone M, Gasperi V, Fezza F, Finazzi-Agro A, Rossi A, Eur J Biochem 2004 271 23-24 4666 4676 10.1111/j.1432-1033.2004.04427.x 15606754 (Pubitemid 40065570)
35. Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System. Chanda P, Gao Y, Mark L, Btesh J, Strassle B, Lu P, Piesla M, Zhang M, Bingham B, Uveges A, et al. Mol Pharmacol 2010 78 996 1003 10.1124/mol.110.068304 20855465
36. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, et al. Nat Neuro 2010 13 9 1113 U1111 10.1038/nn.2616
37. Rates of Skeletal Muscle and Adipose Tissue Glycerol Release in Nonobese and Obese Subjects. Bolinder J, Kerckhoffs D, Moberg E, Hagström-Toft E, Arner P, Diabetes 2000 49 797 802 10.2337/diabetes.49.5.797 10905489 (Pubitemid 30339996)